PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES

The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases. La presente invención proporciona inhibidores...

Full description

Saved in:
Bibliographic Details
Main Authors Dinesh V. PATEL, Gregory BOURNE, Ashok BHANDARI, Xiaoli CHENG, Brian Troy FREDERICK, David LIU, Jie ZHAN
Format Patent
LanguageEnglish
Spanish
Published 27.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases. La presente invención proporciona inhibidores peptídicos novedosos del receptor de interleucina 23 y composiciones y métodos relacionados para utilizar estos inhibidores peptídicos para el tratamiento o la prevención de diversas enfermedades y trastornos, incluidas enfermedades intestinales inflamatorias.
Bibliography:Application Number: MX20180000542